ATEX vs BSX · P/E 16, rev $6.5M vs P/E 20, rev $10.65B
Anterix Inc (ATEX) versus Boston Scientific Corp (BSX) — a side-by-side from cached financials, not a winner call.
Anterix Inc (ATEX) is a telecom services company listed on NASDAQ.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Latest reported ATEX revenue for 2026-03-31 was $6.5M. Net income was $90.6M. Revenue was up 7.8% from 2025-03-31 to 2026-03-31. ATEX currently screens at market cap $1.50B and trailing P/E 16.4.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
ATEX currently screens at market cap $1.50B and trailing P/E 16.4. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Not investment advice. Open the ATEX and BSX stock pages for the full models.
Not investment advice.